Adbiotech Co (XKRX:179530) Receivables Turnover : 1.85 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Adbiotech Co's Revenue for the three months ended in Mar. 2024 was ₩2,930 Mil. Adbiotech Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩1,584 Mil. Hence, Adbiotech Co's Receivables Turnover for the three months ended in Mar. 2024 was 1.85.

Adbiotech Co Receivables Turnover Historical Data

The historical data trend for Adbiotech Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Receivables Turnover Chart

Adbiotech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

6.65

6.26

4.53

3.96

6.04

Adbiotech Co Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial									1.68	1.64	2.04	1.46	1.85

Competitive Comparison of Adbiotech Co's Receivables Turnover

For the Biotechnology subindustry, Adbiotech Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adbiotech Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adbiotech Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Adbiotech Co's Receivables Turnover falls into.

Adbiotech Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Adbiotech Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	10471.95	/ (	(1872.915	+	1596.297)	/	2 )
=	10471.95	/	1734.606
=	6.04

Adbiotech Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	2930.338	/ (	(1596.297	+	1571.556)	/	2 )
=	2930.338	/	1583.9265
=	1.85

Adbiotech Co (XKRX:179530) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Adbiotech Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Adbiotech Co (XKRX:179530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398

Website

http://www.adbiotech.com

Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines